BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9263155)

  • 1. Cyclosporin A in the treatment of adult onset Still's disease.
    Marchesoni A; Ceravolo GP; Battafarano N; Rossetti A; Tosi S; Fantini F
    J Rheumatol; 1997 Aug; 24(8):1582-7. PubMed ID: 9263155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A in the treatment of adult Still's disease.
    Shojania K; Chalmers A; Rangno K
    J Rheumatol; 1995 Jul; 22(7):1391-2. PubMed ID: 7562781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
    Fautrel B; Sibilia J; Mariette X; Combe B;
    Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Efthimiou P; Kontzias A; Ward CM; Ogden NS
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term follow-up of patients with adult-onset Still's disease.
    Akritidis N; Papadopoulos A; Pappas G
    Scand J Rheumatol; 2006; 35(5):395-7. PubMed ID: 17062441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept in the treatment of adult patients with Still's disease.
    Husni ME; Maier AL; Mease PJ; Overman SS; Fraser P; Gravallese EM; Weinblatt ME
    Arthritis Rheum; 2002 May; 46(5):1171-6. PubMed ID: 12115220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose methotrexate treatment in adult Still's disease.
    Aydintug AO; D'Cruz D; Cervera R; Khamashta MA; Hughes GR
    J Rheumatol; 1992 Mar; 19(3):431-5. PubMed ID: 1578459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2345-51. PubMed ID: 9858428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in the treatment of refractory adult Still's disease.
    Mahmud T; Hughes GR
    J Rheumatol; 1999 Sep; 26(9):2067-8. PubMed ID: 10493699
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide and azathioprine combination in refractory adult-onset Still's disease.
    Cefle A
    Ann Pharmacother; 2005 Apr; 39(4):764-7. PubMed ID: 15741418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
    Kalliolias GD; Georgiou PE; Antonopoulos IA; Andonopoulos AP; Liossis SN
    Ann Rheum Dis; 2007 Jun; 66(6):842-3. PubMed ID: 17513574
    [No Abstract]   [Full Text] [Related]  

  • 14. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 15. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
    Youssef J; Lazaro E; Blanco P; Viallard JF
    J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory adult onset Still's disease successfully treated with anakinra.
    Vasques Godinho FM; Parreira Santos MJ; Canas da Silva J
    Ann Rheum Dis; 2005 Apr; 64(4):647-8. PubMed ID: 15374853
    [No Abstract]   [Full Text] [Related]  

  • 18. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy.
    Kurasawa M; Kotani K; Kurasawa G; Shida K; Yamada S; Tago T
    Age Ageing; 2007 Jan; 36(1):104-6. PubMed ID: 17158115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of fulminant adult Still's disease with intravenous pulse methylprednisolone therapy.
    Khraishi M; Fam AG
    J Rheumatol; 1991 Jul; 18(7):1088-90. PubMed ID: 1920313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.